CKD mice were treated with Calcitonin to alleviate hypercalcemia to verify whether Drp1/Fis1-mediated mitochondrial fragmentation involved in neuronal damage caused by CKD-induced hypercalcemia. This evidence concerns the gene DNM1L and chronic kidney disease.